As of Jun 28
| +0.15 / +5.28%|
The 6 analysts offering 12-month price forecasts for BioScrip Inc have a median target of 2.50, with a high estimate of 4.50 and a low estimate of 2.00. The median estimate represents a -16.39% decrease from the last price of 2.99.
The current consensus among 6 polled investment analysts is to Buy stock in BioScrip Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.